Full Text View
Tabular View
No Study Results Posted
Related Studies
The Physiological Consequence of Silicone-Hydrogel Care-Solution Bio-Incompatibility
This study is enrolling participants by invitation only.
First Received: January 23, 2009   Last Updated: January 26, 2009   History of Changes
Sponsor: Southern California College of Optometry
Collaborator: Alcon Laboratories
Information provided by: Southern California College of Optometry
ClinicalTrials.gov Identifier: NCT00829751
  Purpose

The purpose of this study is to more objectively evaluate potential lens-material/care solution bio-incompatibilities. We will do this by measuring corneal staining and the amount of fluorescein dye diffusion into the eye.


Condition Intervention
Contact Lens Solution Toxicity
Device: PureVision lenses soaked in ReNu Multiplus
Device: PureVision lenses soaked in OptiFree RePlenish

Study Type: Interventional
Study Design: Basic Science, Randomized, Double Blind (Subject, Investigator), Placebo Control, Crossover Assignment, Pharmacokinetics/Dynamics Study
Official Title: The Physiological Consequence of Silicone-Hydrogel Care-Solution Bio-Incompatibility

Resource links provided by NLM:


Further study details as provided by Southern California College of Optometry:

Primary Outcome Measures:
  • The level/amount of sodium fluorescein dye in the anterior chamber at post wear timepoints [ Time Frame: On day of experiment ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Corneal staining level post lens wear [ Time Frame: On day of study ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 30
Study Start Date: November 2008
Estimated Study Completion Date: May 2009
Estimated Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
ReNu Multiplus: Active Comparator
Purevision lenses will be soaked in ReNu Multiplus
Device: PureVision lenses soaked in ReNu Multiplus
Purevision silicone hydrogel lenses
OptiFree RePlenish: Active Comparator
PureVision lenses will be soaked in OptiFree RePlenish
Device: PureVision lenses soaked in OptiFree RePlenish
Purevision silicone hydrogel lenses soaked in OptiFree RePlenish

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • At least 18 years of age.
  • Best correctable vision to 20/40 in each eye.
  • Possess a functional spectacle prescription to allow adequate vision during the de-adaptation and fluorometry measurement period.
  • No known ocular or systemic allergies, which may interfere with contact lens wear.
  • No known systemic disease, or need for medication that may interfere with contact les wear (i.e. antihistamines, beta-blockers, steroids, ect.).

Exclusion Criteria:

  • Subjects demonstrating any medical condition that may affect the results of this study SHOULD NOT be enrolled. The following are specific conditions that exclude subjects from enrollment in this study.
  • Eye (ocular) or systemic allergies that may interfere with contact lens wear.
  • Clinically significant corneal swelling (greater than 3 or 4 on a 0-4 scale), corneal blood vessel growth (vascularization), corneal staining, bulbar redness, tarsal redness, or any other abnormality of the cornea that may cause unsafe contact lens wear.
  • Are taking part in any other study or have taken part in a study within the last 14 days.
  • Are pregnant, or anticipating to become pregnant during the course of the study.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00829751

Locations
United States, California
Southern California College of Optometry
Fullerton, California, United States, 92831
Sponsors and Collaborators
Southern California College of Optometry
Alcon Laboratories
Investigators
Principal Investigator: Jerry R Paugh, OD, PhD Southern California College of Optometry
  More Information

No publications provided

Responsible Party: Southern California College of Optometry ( Jerry R. Paugh, OD, PhD, PI )
Study ID Numbers: 08-8
Study First Received: January 23, 2009
Last Updated: January 26, 2009
ClinicalTrials.gov Identifier: NCT00829751     History of Changes
Health Authority: United States: Institutional Review Board

Keywords provided by Southern California College of Optometry:
staining
toxicity
fluorometry
dye diffusion
anterior chamber

ClinicalTrials.gov processed this record on February 08, 2010